Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
HK inno.N

HK inno.N (195940 KS)

40
Analysis
Health CareSouth Korea
HK inno.N Corp. develops and manufactures pharmaceuticals products. The Company develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. HK inno.N conducts businesses across worldwide.
more
bullishHK inno.N
04 Aug 2021 19:09

HK Inno.N Post-Listing Immediate Float Analysis

The real-world float is in the low 20%, which is purely made up of new investors who flowed in through the IPO. This is a fairly neat float...

Logo
220 Views
Share
bullishHK inno.N
28 Jul 2021 08:01

HK Inno.N Book Building Results Analysis

The IPO price of HK Inno.N has been determined at 59,000 won (high end of the IPO price range). The demand ratio among the institutional investors...

Logo
207 Views
Share
bullishHK inno.N
28 Jul 2021 07:24

HK Inno.N Bookbuilding Results: Subscription/Lockup Orders in Detail

HK Inno.N's bookbuilding results are out at DART. This post details the subscription and lockup orders by each investor type.

Logo
237 Views
Share
bullishKrafton
20 Jul 2021 20:44

Krafton Listing Date Confirmed as August 10th: Rebalancing Trading Timeline

The listing date of Krafton has been confirmed as August 10th. So, this post examines the index rebalancing trading timeline.

Logo
330 Views
Share
bullishHK inno.N
07 Jul 2021 03:30

HK Inno.N (Formerly CJ Healthcare) IPO: Offering Detail & Valuation Issues

This post contains information on HK inno.N's initial public offering and summarizes the local street's general view on the valuation.

Logo
513 Views
Share
x